Justices' Guidance Still Needed On Pay-For-Delay Accords

The U.S. Supreme Court on Monday declined to review a pay-for-delay case over the drug Lamictal, but experts said the justices will likely have to revisit the issue at some point...

Already a subscriber? Click here to view full article